First Time Loading...

Opthea Ltd
ASX:OPT

Watchlist Manager
Opthea Ltd Logo
Opthea Ltd
ASX:OPT
Watchlist
Price: 0.645 AUD Market Closed
Updated: Apr 19, 2024

Intrinsic Value

OPT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. [ Read More ]

The intrinsic value of one OPT stock under the Base Case scenario is 0.01 AUD. Compared to the current market price of 0.645 AUD, Opthea Ltd is Overvalued by 98%.

Key Points:
OPT Intrinsic Value
Base Case
0.01 AUD
Overvaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Opthea Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OPT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Opthea Ltd

Provide an overview of the primary business activities
of Opthea Ltd.

What unique competitive advantages
does Opthea Ltd hold over its rivals?

What risks and challenges
does Opthea Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Opthea Ltd.

Provide P/S
for Opthea Ltd.

Provide P/E
for Opthea Ltd.

Provide P/OCF
for Opthea Ltd.

Provide P/FCFE
for Opthea Ltd.

Provide P/B
for Opthea Ltd.

Provide EV/S
for Opthea Ltd.

Provide EV/GP
for Opthea Ltd.

Provide EV/EBITDA
for Opthea Ltd.

Provide EV/EBIT
for Opthea Ltd.

Provide EV/OCF
for Opthea Ltd.

Provide EV/FCFF
for Opthea Ltd.

Provide EV/IC
for Opthea Ltd.

Show me price targets
for Opthea Ltd made by professional analysts.

What are the Revenue projections
for Opthea Ltd?

How accurate were the past Revenue estimates
for Opthea Ltd?

What are the Net Income projections
for Opthea Ltd?

How accurate were the past Net Income estimates
for Opthea Ltd?

What are the EPS projections
for Opthea Ltd?

How accurate were the past EPS estimates
for Opthea Ltd?

What are the EBIT projections
for Opthea Ltd?

How accurate were the past EBIT estimates
for Opthea Ltd?

Compare the revenue forecasts
for Opthea Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Opthea Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Opthea Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Opthea Ltd compared to its peers.

Compare the P/E ratios
of Opthea Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Opthea Ltd with its peers.

Analyze the financial leverage
of Opthea Ltd compared to its main competitors.

Show all profitability ratios
for Opthea Ltd.

Provide ROE
for Opthea Ltd.

Provide ROA
for Opthea Ltd.

Provide ROIC
for Opthea Ltd.

Provide ROCE
for Opthea Ltd.

Provide Gross Margin
for Opthea Ltd.

Provide Operating Margin
for Opthea Ltd.

Provide Net Margin
for Opthea Ltd.

Provide FCF Margin
for Opthea Ltd.

Show all solvency ratios
for Opthea Ltd.

Provide D/E Ratio
for Opthea Ltd.

Provide D/A Ratio
for Opthea Ltd.

Provide Interest Coverage Ratio
for Opthea Ltd.

Provide Altman Z-Score Ratio
for Opthea Ltd.

Provide Quick Ratio
for Opthea Ltd.

Provide Current Ratio
for Opthea Ltd.

Provide Cash Ratio
for Opthea Ltd.

What is the historical Revenue growth
over the last 5 years for Opthea Ltd?

What is the historical Net Income growth
over the last 5 years for Opthea Ltd?

What is the current Free Cash Flow
of Opthea Ltd?

Financials

Balance Sheet Decomposition
Opthea Ltd

Current Assets 166.3m
Cash & Short-Term Investments 157.1m
Receivables 5.8m
Other Current Assets 3.5m
Non-Current Assets 165.2k
PP&E 154.6k
Other Non-Current Assets 10.6k
Current Liabilities 32.6m
Accounts Payable 31.7m
Other Current Liabilities 886.2k
Non-Current Liabilities 180.8m
Long-Term Debt 180.8m
Other Non-Current Liabilities 10.2k
Efficiency

Earnings Waterfall
Opthea Ltd

Revenue
117.1k USD
Cost of Revenue
-233.9k USD
Gross Profit
-116.8k USD
Operating Expenses
-165.1m USD
Operating Income
-165.2m USD
Other Expenses
3.6m USD
Net Income
-161.6m USD

Free Cash Flow Analysis
Opthea Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

OPT Profitability Score
Profitability Due Diligence

Opthea Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROIC
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
27/100
Profitability
Score

Opthea Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

OPT Solvency Score
Solvency Due Diligence

Opthea Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Low D/E
Positive Net Debt
65/100
Solvency
Score

Opthea Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OPT Price Targets Summary
Opthea Ltd

There are no price targets for OPT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

OPT Price
Opthea Ltd

1M 1M
+4%
6M 6M
+90%
1Y 1Y
-5%
3Y 3Y
-56%
5Y 5Y
-9%
10Y 10Y
+267%
Annual Price Range
0.645
52w Low
0.315
52w High
0.75
Price Metrics
Average Annual Return 54.31%
Standard Deviation of Annual Returns 173.25%
Max Drawdown -92%
Shares Statistics
Market Capitalization 427.5m AUD
Shares Outstanding 662 809 000
Percentage of Shares Shorted
N/A

OPT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Opthea Ltd Logo
Opthea Ltd

Country

Australia

Industry

Biotechnology

Market Cap

427.5m AUD

Dividend Yield

0%

Description

Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. The company is headquartered in Melbourne, Victoria. The firm is engaged in developing and commercializing therapies primarily for eye diseases. The firm's lead product candidate OPT-302, is a soluble form of vascular endothelial growth factors-3 (VEGFR 3) in clinical development as a therapy for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The firm's technology platform focuses on vascular endothelial growth factors, such as VEGF C, VEGF D and VEGF Receptor 3 for the treatment of diseases associated with blood and lymphatic vessel growth (angiogenesis and lymphangiogenesis), as well as vascular leakage. The company has also conducted various activities to support its clinical development programs in wet AMD and DME, including clinical data analysis and manufacturing of OPT-302 for use in Phase III clinical trials.

Contact

VICTORIA
Melbourne
Suite 0403, Level 4, 650 Chapel Street, South Yarra
+61398260399.0
https://opthea.com/

IPO

1985-04-09

Employees

-

Officers

Founder, Chief Innovation Officer & Executive Director
Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D.
Chief Commercial Officer
Ms. Judith J. Robertson B.A., M.B.A.
VP of Finance & Company Secretary
Ms. Karen Adams CPA
Chief Executive Officer
Dr. Frederic Guerard M.S., Pharm.D.
Chief Financial Officer
Mr. Peter F. Lang M.B.A.
Executive Director of Human Resources
Ms. Sarika Gulhar Ph.D.
Show More
Head of Chemistry, Manufacturing & Controls Development
Dr. Michael Gerometta Ph.D.
Senior Vice President of Global Clinical Operations
Mr. Bruno Gagnon BPHARM, M.Sc.
Chief Medical Officer
Dr. Kenneth Sall
Senior Vice President of Regulatory Affairs
Dr. Fang Li Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one OPT stock?

The intrinsic value of one OPT stock under the Base Case scenario is 0.01 AUD.

Is OPT stock undervalued or overvalued?

Compared to the current market price of 0.645 AUD, Opthea Ltd is Overvalued by 98%.